Cargando…
SARS-CoV-2 variants – Evolution, spike protein, and vaccines
Despite the rising natural and vaccines mediated immunity, several countries have experienced a resurgence of the Coronavirus disease of 2019 (COVID-19) due to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. From Alpha to Omicron, the variants of concern (VOC)...
Autores principales: | Chen, Kai-Wei K., Tsung-Ning Huang, Daniel, Huang, Li-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072773/ https://www.ncbi.nlm.nih.gov/pubmed/35526825 http://dx.doi.org/10.1016/j.bj.2022.04.006 |
Ejemplares similares
-
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
por: Beck, Annika, et al.
Publicado: (2023) -
Mutations and Evolution of the SARS-CoV-2 Spike Protein
por: Magazine, Nicholas, et al.
Publicado: (2022) -
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations
por: Solanki, Kundan, et al.
Publicado: (2022) -
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021) -
Antibodies against spike protein of SARS-CoV-2 variants in bovine whey IgG enriched fraction
por: Oshiro, Satoshi, et al.
Publicado: (2022)